Skip to main content
. Author manuscript; available in PMC: 2010 Mar 1.
Published in final edited form as: Biochim Biophys Acta. 2009 Jan 15;1793(3):477–488. doi: 10.1016/j.bbamcr.2009.01.004

Table 1.

Co-expression of gastrin precursors and the colon cancer stem cell marker CD133 in human colorectal tumours.

Number of positive Tumours
Differentiation Staining ProG G-gly CD133 Co-Staining ProG & CD133 Co-Staining G-gly & CD133
Number Trs
Well 24 20
83.2%		 15
62.4%		 17
70.7%		 16
66.6%		 14
58.2%
Moderately 22 16
72.6%		 12
54.5%		 14
63.6%		 13
59%		 12
54.5%
Poorly 10 8
80%		 3
30%		 4
40%		 4
40%		 3
30%
ND 4 4
100%		 4
100%		 4
100%		 4
100%		 4
100%
TOTAL 60 48
80% 		34
56.7% 		39
65% 		37
61.7% 		33
55%

ProG: Progastrin, Number Trs: Number of Tumours, ND: Not Determined.